200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 87760-53-0
87760-53-0 | 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aα,4β,7β,7aα)-
CAS No: 87760-53-0 Catalog No: AG0036C9 MDL No:MFCD00904852
Product Description
Catalog Number:
AG0036C9
Chemical Name:
4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aα,4β,7β,7aα)-
CAS Number:
87760-53-0
Molecular Formula:
C21H29N5O2
Molecular Weight:
383.4873
MDL Number:
MFCD00904852
IUPAC Name:
(1S,2R,6S,7R)-4-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
InChI:
InChI=1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18-
InChI Key:
CEIJFEGBUDEYSX-FZDBZEDMSA-N
SMILES:
O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
UNII:
190230I669
Properties
Complexity:
572
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
4
Defined Bond Stereocenter Count:
0
Exact Mass:
383.232g/mol
Formal Charge:
0
Heavy Atom Count:
28
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
383.496g/mol
Monoisotopic Mass:
383.232g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9
Literature
| Title | Journal |
|---|---|
| Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120901 |
| 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux. | Neuroreport 20120509 |
| Effect of transient blockade of N-methyl-D-aspartate receptors at neonatal stage on stress-induced lactate metabolism in the medial prefrontal cortex of adult rats: role of 5-HT1A receptor agonism. | Synapse (New York, N.Y.) 20120501 |
| The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats. | Psychopharmacology 20120501 |
| Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress. | Human psychopharmacology 20120501 |
| [Efficacy and safety of tandospirone in the treatment of patients with anxiety disorder]. | Zhonghua yi xue za zhi 20120403 |
| [First death case of serotonin syndrome in Japan induced by fluvoxamine and tandospirone]. | Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20111201 |
| Determination of tandospirone in human plasma by a liquid chromatography-tandem mass spectrometry method. | Analytical and bioanalytical chemistry 20110701 |
| Efficacy of a 5-HT1a receptor agonist in atopic dermatitis. | Clinical and experimental dermatology 20101201 |
| Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study. | Cerebellum (London, England) 20101201 |
| Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report. | Journal of clinical psychopharmacology 20101201 |
| Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome. | Journal of medicinal chemistry 20101111 |
| Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats. | Psychopharmacology 20101001 |
| Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells. | Clinical and experimental dermatology 20100701 |
| The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers. | Human psychopharmacology 20100401 |
| Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. | The American journal of gastroenterology 20091101 |
| Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. | Journal of pharmacological sciences 20090401 |
| Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. | European journal of pharmacology 20081112 |
| Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. | Advances in therapy 20081001 |
| Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4. | Psychiatry and clinical neurosciences 20081001 |
| Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test. | Progress in neuro-psychopharmacology & biological psychiatry 20080701 |
| Effects of selective 5-HT1A agonist tandospirone on the rate and rhythmicity of binocular rivalry. | Psychopharmacology 20080601 |
| Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. | Sleep medicine 20080301 |
| Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report. | Movement disorders : official journal of the Movement Disorder Society 20080101 |
| Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071001 |
| Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. | Schizophrenia research 20070901 |
| Effect of tandospirone on sleep latency in rats placed on a grid suspended over water. | Journal of pharmacological sciences 20070901 |
| Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
| Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
| A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia. | The international journal of neuropsychopharmacology 20070401 |
| Paroxetine-induced bruxism effectively treated with tandospirone. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. | European journal of drug metabolism and pharmacokinetics 20070101 |
| Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. | European journal of drug metabolism and pharmacokinetics 20070101 |
| Use of a serotonin 1A receptor agonist to treat restless legs syndrome. | Journal of clinical psychopharmacology 20061201 |
| Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. | Brain research 20060927 |
| The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060701 |
| Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone. | Therapeutic drug monitoring 20060201 |
| Synthesis of some n-substituted derivatives of 1-(1h-pyrrole-1 -ylmethyl)- 10-oxa-4-azatricyclo [5.2.1.0(2,6)]dec-8-ene-3,5-dione with an expected anxiolytic activity. | Acta poloniae pharmaceutica 20060101 |
| Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. | Alimentary pharmacology & therapeutics 20050601 |
| Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. | Alimentary pharmacology & therapeutics 20050601 |
| Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. | Naunyn-Schmiedeberg's archives of pharmacology 20050101 |
| Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs? | Journal of psychiatry & neuroscience : JPN 20041101 |
| Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. | British journal of pharmacology 20040801 |
| Serotonin 1A receptors in memory function. | The American journal of psychiatry 20040801 |
| [Postherpetic neuralgia alleviated by an SSRI fluvoxamine: two cases of PHN accompanied with depression were treated with fluvoxamine]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401 |
| [Dementia induced by antianxiety drugs]. | Nihon rinsho. Japanese journal of clinical medicine 20040101 |
| Effects of tandospirone on '5-HT1A receptor-associated symptoms' in patients with Machado-Josephe disease: an open-label study. | Clinical neuropharmacology 20040101 |
| Oral tandospirone and clonidine provide similar relief of preoperative anxiety. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20040101 |
| [Hippocampal serotonin 1A receptor and memory function]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101 |
| 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease. | Psychiatry and clinical neurosciences 20031201 |
| Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial. | Psychiatry and clinical neurosciences 20030401 |
| Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. | The American journal of psychiatry 20030201 |
| [Pharmacology of anxiolytics and their therapeutic use]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Organic anxiety disorder]. | Ryoikibetsu shokogun shirizu 20030101 |
| In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response. | Psychopharmacology 20021201 |
| Prevention of nausea and vomiting with tandospirone in adults after tympanoplasty. | Anesthesia and analgesia 20021101 |
| Effects of serotonin 1A agonist on acute spinal cord injury. | Spinal cord 20021001 |
| [Serotonin syndrome caused by tandospirone citrate alone]. | Rinsho shinkeigaku = Clinical neurology 20020901 |
| Effectiveness of serotonin (5-HT)1A receptor agonist in a patient with psychogenic apneusis. | Journal of clinical psychopharmacology 20020601 |
| Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia. | Human psychopharmacology 20020601 |
| Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease. | Psychiatry and clinical neurosciences 20020401 |
| [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease]. | No to shinkei = Brain and nerve 20020201 |
| [Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy]. | Rinsho shinkeigaku = Clinical neurology 20020101 |
| The anxiolytic effects of the 5-hydroxytryptamine-1A agonist tandospirone before otolaryngologic surgery. | Anesthesia and analgesia 20011101 |
| [Successful treatment of emotional disturbances following non-herpetic limbic encephalitis by serotonergic agents. A case report]. | Rinsho shinkeigaku = Clinical neurology 20011101 |
| Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. | The American journal of psychiatry 20011001 |
| Inhibitory effects of tandospirone, a 5-HT1A agonist, on medial vestibular nucleus neurons responding to lateral roll tilt stimulation in rats. | Brain research 20010810 |
| Effects of tandospirone, a serotonin-1A agonist, on the hypothalamo-pituitary-gonadal axis of male patients. | Neuro endocrinology letters 20010801 |
| Conformational analysis of tandospirone in aqueous solution: lead evolution of potent dopamine D4 receptor ligands. | Bioorganic & medicinal chemistry letters 20010507 |
| Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist. | Journal of psychiatry & neuroscience : JPN 20010301 |
| Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone. | General hospital psychiatry 20010101 |
| Alpha 2-adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming. | Methods and findings in experimental and clinical pharmacology 20010101 |
| Amelioration of frozen gait by tandospirone, a serotonin 1A agonist, in a patient with pure akinesia developing resistance to L-threo-3,4-dihydroxyphenylserine. | Clinical neuropharmacology 20010101 |
| [A case of progressive supranuclear palsy improved with tandospirone citrate]. | Rinsho shinkeigaku = Clinical neurology 20010101 |
| Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo. | Pharmacology, biochemistry, and behavior 20010101 |
| Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study. | European journal of pharmacology 19980821 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.